Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jan;4(1):59-67.
doi: 10.1007/s12687-012-0118-9. Epub 2012 Oct 7.

Screening criteria: the need to deal with new developments and ethical issues in newborn metabolic screening

John Forman  1 , Fiona Coyle, Jill Levy-Fisch, Pat Roberts, Sharon Terry, Michael Legge
Affiliations

Screening criteria: the need to deal with new developments and ethical issues in newborn metabolic screening

John Forman et al. J Community Genet. 2013 Jan.

Abstract

Newborn metabolic screening is the most widespread application of screening technology and provides the most comprehensive application of genetics in health services, where the Guthrie blood spot cards allow screening for metabolic diseases in close to 100 % of all newborn babies. Despite over 40 years of use and significant benefits to well in excess of 100,000 children worldwide, there is remarkably little consensus in what conditions should be screened for and response to new advances in medicine relating to programme expansion. In this article, the international criteria for newborn metabolic screening are considered, and we propose that these criteria are poorly developed in relation to the baby, its family and society as a whole. Additionally, the ethical issues that should inform the application of screening criteria are often not developed to a level where a consensus might easily be achieved. We also consider that when family interests are factored in to the decision-making process, they have a significant influence in determining the list of diseases in the panel, with countries or states incorporating family and societal values being the most responsive. Based on our analysis, we propose that decision criteria for metabolic screening in the newborn period should be adapted to specifically include parent and family interests, community values, patients' rights, duties of government and healthcare providers, and ethical arguments for action in the face of uncertainty.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Access to Medicines Coalition (2007) Submission on the MoH consultation document: towards a New Zealand medicines strategy. Accessed online October 2011 at: http://www.nzordgroups.org.nz/cms/imagelibrary/10042.pdf
    1. Alexander D, van Dyck P. A vision of the future of newborn screening. Pediatrics. 2006;117:350–354. doi: 10.1542/peds.2005-3085. - DOI - PubMed
    1. Andermann A, Blancquaert I, Beauchamp S, Déry V. Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. Bull World Health Organ. 2008;86:241–320. doi: 10.2471/BLT.07.050112. - DOI - PMC - PubMed
    1. Avard D, Vallance H, Greenberg C, Potter B. Newborn screening by tandem mass spectrometry—ethical and social issues. Can J Public Health. 2007;98:284–286. - PMC - PubMed
    1. Bailey M, Murray T. Ethics, evidence, and cost in newborn screening. Hast Cent Rep. 2008;38:23–31. - PubMed

LinkOut - more resources